Article
Genetic variation underlying psychosis-inducing effects of cannabis: critical review and future directions.
Current pharmaceutical design - 1 Jan 2012
Decoster Jeroen, van Os Jim, Myin-Germeys Inez, De Hert Marc, van Winkel Ruud
Abstract excerpt
Cannabis use is associated with an increased risk for psychotic disorder, yet most cannabis users do not develop psychosis, suggesting that other factors are also involved. This paper reviews the available evidence suggesting that differential sensitivity to the psychosis-inducing effects of cannabis may be related to underlying genetic liability. There is robust evidence that persons at psychometric risk for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
